相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data
Lisette Warkentin et al.
BMJ OPEN (2023)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Usefulness of transesophageal echocardiography before cardioversion in atrial arrhythmias
Katarzyna Kosmalska et al.
CARDIOLOGY JOURNAL (2021)
Antithrombotic treatmentmanagement in low stroke risk patients undergoing cardioversion of atrial fibrillation < 48 h duration: results of an EHRA survey
Federico Migliore et al.
EUROPACE (2021)
How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group
Andrea Rubboli et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2021)
Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey
Michal M. Farkowski et al.
EUROPACE (2020)
Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial
Monika Koziel et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study
Michele Massimo Gulizia et al.
EUROPACE (2019)
Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus
Agnieszka Kaplon-Cieslicka et al.
HEART (2019)
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials
Kang-Ling Wang et al.
EUROPEAN HEART JOURNAL (2019)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion
Saga Itainen et al.
EUROPACE (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
Nelson Telles-Garcia et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution
Michael S. Wu et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2018)
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin
Dipak Kotecha et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes The ORBIT-AF II Registry
Benjamin A. Steinberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2015)
Prognostic Significance of Left Atrial Appendage Sludge'' in Patients with Atrial Fibrillation: A New Transesophageal Echocardiographic Thromboembolic Risk Factor
Boris S. Lowe et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
分享论文
